Gastrointestinal (GI) toxicity is one of the
major proble
ms associated with antiinfla
mmatorydrugs. The co
mplexation of the powerful antiinfla
mmatory drug (IndoH) by
metal ions, as a
means of reducing GI toxicity, has been studied. The in vitro superoxide dis
mutase (SOD)activity, in vivo antiinfla
mmatory activity, and gastrointestinal ulcerogenic properties of IndoH,[Cu
2(Indo)
4(DMF)
2], and [Zn
2(Indo)
4(DMA)
2] are reported. No SOD activity was observed forIndoH or [Zn
2(Indo)
4(DMA)
2], but [Cu
2(Indo)
4(DMF)
2] inhibited the reduction of nitrobluetetrazoliu
m (NBT) at an IC
50 value of 0.23
mages/entities/
mgr.gif">M. All three co
mpounds exhibited antiinfla
mmatoryactivity in
male Sprague-Dawley rats at an equivalent Indo dose of 10
mg/kg following oralad
ministration of the drugs in 2% CMC solution. The severity of the toxicity (
macroscopiculcerations) in the sto
mach following oral dosing with [Zn
2(Indo)
4(DMF)
2] was not significantlylower than that induced by IndoH (
P = 0.78). Gastric ulcerations induced by [Cu
2(Indo)
4(DMF)
2]were significantly lower than those induced by IndoH or [Zn
2(Indo)
4(DMA)
2] (
P = 0.0012 and
P = 0.0175, respectively) but significantly greater than the control (
P = 0.0013). The intestinalulcerations induced by [Cu
2(Indo)
4(DMF)
2] or [Zn
2(Indo)
4(DMA)
2] were approxi
mately 15 ti
meslower than those of IndoH. A further indicator of gastrointestinal toxicity, caecal hae
moglobin,increased in the following order: control < [Cu
2(Indo)
4(DMF)
2] < [Zn
2(Indo)
4(DMA)
2] < IndoH.[Cu
2(Indo)
4(DMF)
2] exhibited the
most pro
mising results of the Indo co
mplexes assayed, inthat it exhibited SOD activity and the lowest gastrointestinal da
mage while also exhibitingantiinfla
mmatory activity that was co
mparable to that for IndoH. Low-te
mperature EPRanalyses also showed that the for
mulation used for [Cu
2(Indo)
4(DMF)
2] ad
ministration wascrucial to the integrity of the co
mplex.